Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Payoneer Global Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Payoneer Global Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091988
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Revenues | $274,258 | 260,614 | $535,853 | 507,231 |
| Transaction costs | 37,682 | 40,566 | 72,884 | 79,915 |
| Other operating expenses | 41,260 | 42,703 | 81,271 | 84,361 |
| Research and development expenses | 46,968 | 37,387 | 90,294 | 74,658 |
| Sales and marketing expenses | 61,770 | 57,312 | 119,882 | 112,038 |
| General and administrative expenses | 48,421 | 37,016 | 84,428 | 66,920 |
| Depreciation and amortization | 21,224 | 15,553 | 40,140 | 29,943 |
| Total operating expenses | 257,325 | 230,537 | 488,899 | 447,835 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Payoneer Global Inc.'s R&D?
- Payoneer Global Inc. (PAYO) reported R&D of $46.97M in Q2 2026.
- How has Payoneer Global Inc.'s R&D changed year-over-year?
- Payoneer Global Inc.'s R&D increased by 25.6% year-over-year, from $37.39M to $46.97M.
- What is the long-term trend for Payoneer Global Inc.'s R&D?
- Over 4 years (2021 to 2025), Payoneer Global Inc.'s R&D has grown at a 17.8% compound annual growth rate (CAGR), from $80.76M to $155.42M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Payoneer Global Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude